Phase II clinical study of DD-723 (perflubutane): dose-response study in patients with breast tumors.

Miyamoto, Yukio; Ito, Toshikazu; Takada, Etsuo; Omoto, Kiyoka; Hirai, Toshiko; Sekiguchi, Ryuzo; Okuno, Toshitaka; Kanazawa, Shinsaku; Nakata, Norio; Igarashi, Takao

Miyamoto, Yukio; Ito, Toshikazu; Takada, Etsuo; Omoto, Kiyoka; Hirai, Toshiko; Sekiguchi, Ryuzo; Okuno, Toshitaka; Kanazawa, Shinsaku; Nakata, Norio; Igarashi, Takao.

Afiliación

Miyamoto Y; Department of Diagnostic Imaging, Jikei University Hospital, 3-19-18 Nishishinbashi, Minato, Tokyo, 105-8471, Japan. miyamoto@jikei.ac.jp.
Ito T; Department of Surgery, Rinku General Medical Center, Osaka, Japan.
Takada E; Center of Medical Ultrasonics, Dokkyo Medical University, Tochigi, Japan.
Omoto K; Department of Laboratory Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Hirai T; Department of Endoscopy and Ultrasound, Nara Medical University Hospital, Nara, Japan.
Sekiguchi R; Department of Diagnostic Imaging, Tochigi Cancer Center, Tochigi, Japan.
Okuno T; Kobe Urban Breast Clinic, Hyogo, Japan.
Kanazawa S; Department of Radiology, Toho University Omori Hospital, Tokyo, Japan.
Nakata N; Department of Diagnostic Imaging, Jikei University Hospital, 3-19-18 Nishishinbashi, Minato, Tokyo, 105-8471, Japan.
Igarashi T; Department of Diagnostic Imaging, Jikei University Hospital, 3-19-18 Nishishinbashi, Minato, Tokyo, 105-8471, Japan.

J Med Ultrason (2001) ; 39(2): 79-86, 2012 Apr.

Article en En | MEDLINE | ID: mdl-27278847

Palabras clave

Breast tumors; Phase II clinical study; Sonazoid; Ultrasound contrast medium

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: J Med Ultrason (2001) Año: 2012 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google